BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9159774)

  • 1. Commentary: patient counseling and education.
    Mahon SM
    Oncol Nurs Forum; 1997 May; 24(4):635-6. PubMed ID: 9159774
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing.
    Bernhardt BA; Geller G; Doksum T; Metz SA
    Oncol Nurs Forum; 2000; 27(1):33-9. PubMed ID: 10660921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do physicians discuss genetic testing with family-history-positive breast cancer patients?
    Polednak AP
    Conn Med; 1998 Jan; 62(1):3-7. PubMed ID: 9509706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Schwartz MD; Tercyak KP; Peshkin BN; Valdimarsdottir H
    Nat Clin Pract Oncol; 2005 Jan; 2(1):24-5. PubMed ID: 16264852
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of bilateral prophylactic mastectomy.
    Eisinger F; Huiart L; Sobol H
    J Clin Oncol; 2005 Feb; 23(6):1330-1; author reply 1331-2. PubMed ID: 15718344
    [No Abstract]   [Full Text] [Related]  

  • 9. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the genetic risk of breast cancer.
    McCance KL; Jorde LB
    Nurse Pract; 1998 Aug; 23(8):14-6, 19-20, 23-7; quiz 28-9. PubMed ID: 9718599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer susceptibility genes.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(22):12-4; quiz 14. PubMed ID: 10542765
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary breast cancer. Psychosocial issues and family physicians' role.
    Carroll JC; Heisey RE; Warner E; Goel V; McCready DR
    Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
    Mancini J; Noguès C; Adenis C; Berthet P; Bonadona V; Chompret A; Coupier I; Eisinger F; Fricker JP; Gauthier-Villars M; Lasset C; Lortholary A; N'Guyen TD; Vennin P; Sobol H; Stoppa-Lyonnet D; Julian-Reynier C
    Eur J Cancer; 2006 May; 42(7):871-81. PubMed ID: 16563745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaring up patients.
    Ortolon K
    Tex Med; 2008 Aug; 104(8):43-6. PubMed ID: 19306543
    [No Abstract]   [Full Text] [Related]  

  • 15. Should insurance pay for preventive services suggested by genetics?
    Lawrence J
    Manag Care; 1997 Jan; 6(1):42-6. PubMed ID: 10164532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hard choices when breast cancer threatens.
    Mayes JR
    JAAPA; 2001 Mar; 14(3):6, 9. PubMed ID: 11523187
    [No Abstract]   [Full Text] [Related]  

  • 17. Professional challenges in cancer genetic testing: who is the patient?
    Chan-Smutko G; Patel D; Shannon KM; Ryan PD
    Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing hereditary breast cancer risk.
    Cancer Pract; 1999; 7(6):279-84. PubMed ID: 10732524
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
    Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.